Deborah Millar demonstrates self-defense moves as part of the R.A.D. class for women at Penn Medicine Princeton Health. (Image: Penn Medicine Service in Action)
The best defense is an empowered one
To gain control over their personal safety, many women turn to R.A.D. (Rape Aggression Defense), a nationally recognized program that teaches realistic self-defense tactics and techniques.
Entering a new phase in cell therapy for glioblastoma
Donald M. O’Rourke, director of the Glioblastoma Translational Center of Excellence at Penn Medicine, and others are exploring cellular immunotherapies as a potential better option for deadly brain cancer glioblastoma multiforme.
The Abramson Cancer Center’s Summer Health Experience, or SHE program, exposes students like Bintou Samassa (bottom left) to a career in cancer research. (Image: Penn Medicine News)
New program inspires underrepresented young women to cancer research
The Abramson Cancer Center’s Summer Health Experience, or SHE, program introduces young women to careers in cancer research. Statistics show that Black and Latinx women are severely underrepresented in the health sciences.
Penn-led consortium identifies more genetic markers for inherited testicular cancer
A new meta-analysis of nearly 200,000 men revealed 22 new genetic locations that could be susceptible to inherited testicular germ cell tumors—an increase of 40%.
PHMC Public Health Campus on Cedar. (Image: Penn Medicine News)
Penn Medicine’s new center to improve surgical equity for vulnerable patients
The Center for Surgical Health provides a new access point into sustainable, high-value surgical care for patients who typically rely on the emergency room for treatment.
Penn researchers are looking to mRNA vaccines for applications outside of infectious diseases, as they can not only prompt strong antibody responses to fight off invaders, like COVID-19, but also potent cytotoxic T cell responses.
Black and white women have same mutations linked to breast cancer risk
The prevalence of genetic mutations associated with breast cancer in Black and white women is the same, but the takeaway is not to change testing guidelines based on race alone, but focus on ensuring equal access to and uptake of testing to minimize disparities in care and outcomes.
‘Electronic nose’ accurately sniffs out hard-to-detect cancers
An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95% accuracy.
